Abstract
Tamoxifen (TAM)-induced DNA adduct formation in mouse skin was determined by a nuclease P1-enhanced 32P-postlabelling technique. Topical application of TAM significantly induced a number of DNA-adducts in mouse skin in a dose- and time-dependent manner. When SENCAR mice were topically treated with different doses of TAM for 6 h, total DNA adduct levels in skin were increased by 2.5- (1 mumol TAM), 4.5- (5 mumol TAM) and 4.8-fold (10 mumol TAM), respectively. In addition, at least four novel DNA adducts were observed. Time-course studies showed that TAM-induced DNA adducts reach a peak at 6 h post-treatment. However, the pattern of TAM-induced DNA adducts was different from that induced by DMBA (a potent skin carcinogen). TAM has been found to form DNA-adducts in the liver and kidney of rodents. Our work confirms the genotoxic effects observed by other investigators by showing that TAM also causes DNA-adducts formation in mouse skin. Since TAM is widely used for the treatment of breast cancer and currently for chemo-prevention trials, further studies should be conducted to assess the potential risk of long-term use of TAM in humans.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
